Lexicon Pharmaceuticals
LXRX
$1.58
Share price
-0.32%
Change (1 day)
-34.10%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) - Total debt
Total debt on the balance sheet as of December 2023 : $0.10 B
According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is $0.10 B. A company’s total debt is the sum of all current and non-current debts.
Lexicon Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $55.29 M | 2326.24% |
| 2021-12-31 | $2.27 M | -82.21% |
| 2020-12-31 | $12.81 M | -94.79% |
| 2019-12-31 | $0.24 B | 0.3% |
| 2018-12-31 | $0.24 B | -0.27% |
| 2017-12-31 | $0.24 B | 142.17% |
| 2016-12-31 | $0.10 B | -1.45% |
| 2015-12-31 | $0.10 B | -4.39% |
| 2014-12-31 | $0.10 B | 392.15% |
| 2013-12-31 | $21.87 M | -6.71% |
| 2012-12-31 | $23.45 M | -5.8% |
| 2011-12-31 | $24.89 M | -12.6% |
| 2010-12-31 | $28.48 M | -57.47% |
| 2009-12-31 | $66.96 M | 119.61% |
| 2008-12-31 | $30.49 M | -2.81% |
| 2007-12-31 | $31.37 M | -2.53% |
| 2006-12-31 | $32.18 M | -12.86% |
| 2005-12-31 | $36.94 M | -1.84% |
| 2004-12-31 | $37.63 M | -33.21% |
| 2003-12-31 | $56.34 M | 1308.6% |
| 2002-12-31 | $4 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 32,820.69% | 🇺🇸 USA |
 Illumina ILMN | $2.26 B | 2,032.67% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $2.70 B | 2,448.37% | 🇺🇸 USA |
 Ultragenyx RARE | $43.16 M | -59.30% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $6.16 M | -94.19% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.26 B | 150.95% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.33 B | 217.72% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 933.10% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $41.84 M | -60.55% | 🇺🇸 USA |